Zhejiang Jiuzhou Pharm Co Ltd (603456) - Total Liabilities

Latest as of March 2026: CN¥1.64 Billion CNY ≈ $239.29 Million USD

Based on the latest financial reports, Zhejiang Jiuzhou Pharm Co Ltd (603456) has total liabilities worth CN¥1.64 Billion CNY (≈ $239.29 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Zhejiang Jiuzhou Pharm Co Ltd - Total Liabilities Trend (2008–2025)

This chart illustrates how Zhejiang Jiuzhou Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Zhejiang Jiuzhou Pharm Co Ltd (603456) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Zhejiang Jiuzhou Pharm Co Ltd Competitors by Total Liabilities

The table below lists competitors of Zhejiang Jiuzhou Pharm Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Kfin Technologies Limited
NSE:KFINTECH
India Rs11.01 Billion
Agios Pharm
NASDAQ:AGIO
USA $75.88 Million
Beijer Alma AB (publ)
ST:BEIA-B
Sweden Skr5.10 Billion
Ivanhoe Electric Inc.
NYSE MKT:IE
USA $92.39 Million
Tien Phong Commercial Joint Stock Bank
VN:TPB
Vietnam ₫459.85 Trillion
Greif Bros Corporation
NYSE:GEF
USA $2.52 Billion
Wuxi Shangji Automation Co Ltd
SHG:603185
China CN¥15.27 Billion
Bukit Asam Tbk PT
JK:PTBA
Indonesia Rp19.56 Trillion

Liability Composition Analysis (2008–2025)

This chart breaks down Zhejiang Jiuzhou Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zhejiang Jiuzhou Pharm Co Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.83 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Jiuzhou Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Jiuzhou Pharm Co Ltd (2008–2025)

The table below shows the annual total liabilities of Zhejiang Jiuzhou Pharm Co Ltd from 2008 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥1.81 Billion
≈ $265.21 Million
-28.01%
2024-12-31 CN¥2.52 Billion
≈ $368.41 Million
+8.57%
2023-12-31 CN¥2.32 Billion
≈ $339.33 Million
-8.77%
2022-12-31 CN¥2.54 Billion
≈ $371.94 Million
+3.19%
2021-12-31 CN¥2.46 Billion
≈ $360.46 Million
+28.59%
2020-12-31 CN¥1.92 Billion
≈ $280.32 Million
+5.73%
2019-12-31 CN¥1.81 Billion
≈ $265.14 Million
+243.94%
2018-12-31 CN¥526.81 Million
≈ $77.09 Million
+14.08%
2017-12-31 CN¥461.77 Million
≈ $67.57 Million
+6.89%
2016-12-31 CN¥432.01 Million
≈ $63.22 Million
-47.28%
2015-12-31 CN¥819.46 Million
≈ $119.91 Million
+31.12%
2014-12-31 CN¥624.98 Million
≈ $91.45 Million
-23.25%
2013-12-31 CN¥814.26 Million
≈ $119.15 Million
+9.11%
2012-12-31 CN¥746.26 Million
≈ $109.20 Million
+14.28%
2011-12-31 CN¥653.04 Million
≈ $95.56 Million
+27.54%
2010-12-31 CN¥512.03 Million
≈ $74.93 Million
+31.81%
2009-12-31 CN¥388.45 Million
≈ $56.84 Million
-5.55%
2008-12-31 CN¥411.27 Million
≈ $60.18 Million
--

About Zhejiang Jiuzhou Pharm Co Ltd

SHG:603456 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.71 Billion
CN¥11.67 Billion CNY
Market Cap Rank
#6858 Global
#1532 in China
Share Price
CN¥13.12
Change (1 day)
+1.16%
52-Week Range
CN¥12.18 - CN¥21.87
All Time High
CN¥60.21
About

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecule, drug product, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and … Read more